Evidence map›Paper›PMID 29033910›Full record

ArticleFrontiers in microbiology2017

Resistance of Animal Strains of

Marisa Haenni, Maxime Bour, Pierre Châtre, Jean-Yves Madec, Patrick Plésiat, Katy Jeannot

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Regulation, structure, and activity of theAntimicrobial agents and chemotherapy · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Rapid typing ofFrontiers in microbiology · 2024
    Article
  12. Article
  13. The Impact of the Virulence ofVeterinary sciences · 2023
    Article
  14. Review
  15. Antimicrobial Resistance and Genetic Diversity ofPathogens (Basel, Switzerland) · 2022
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Prediction of Potential Drug Targets and Vaccine Candidates Against Antibiotic-ResistantInternational journal of peptide research and therapeutics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Marisa HaenniUnité Antibiorésistance et Virulence Bactériennes, ANSES-Université de LyonLyon, France.
Maxime BourCentre National de Référence de la Résistance aux Antibiotiques, Centre Hospitalier Universitaire de BesançonBesançon, France.
Pierre ChâtreUnité Antibiorésistance et Virulence Bactériennes, ANSES-Université de LyonLyon, France.
Jean-Yves MadecUnité Antibiorésistance et Virulence Bactériennes, ANSES-Université de LyonLyon, France.
Patrick PlésiatCentre National de Référence de la Résistance aux Antibiotiques, Centre Hospitalier Universitaire de BesançonBesançon, France.
Katy JeannotCentre National de Référence de la Résistance aux Antibiotiques, Centre Hospitalier Universitaire de BesançonBesançon, France.
CNR de la Résistance aux Antibiotiques · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenems are major antibiotics reserved to human medicine. This study aimed to investigate the mechanisms of carbapenem resistance of a selection of

Indexed as

carbapenemsefflux pumpMexAB-OprMMexXY/OprMOprD porinP. aeruginosaveterinary strains

Identifiers

PMID29033910
PMCPMC5626926
OpenAlexW2757992348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.